Derivation Web

source_927d2c6b22334fde

study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
Clinical experience with the <scp>BCL</scp>2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Long-Term Results of t…